Chewy's Pharmacy Push Doomed

Chewy can sell pet products at scale, but pharmacy and telehealth depend on veterinarian trust, clinical workflow, and being seen as a care provider, not just a retailer. In pet care, the prescription often starts with the vet relationship, and the refill, follow up, and emergency handoff stay tied to that relationship. A company built around logistics and customer support can win the box shipment, while still losing the medical layer that controls prescribing and long term care.

• Pet telehealth is structurally different from human D2C telehealth. There is no simple high volume pet equivalent of ED drugs, and pets cannot self report symptoms, so virtual care is much better at triage and follow up than remote diagnosis. That makes pharmacy harder to separate from exams, labs, and in person care.
  1 sacra 3 sacra
• The strongest comparables are integrated clinic platforms like Modern Animal. Its app handles chat triage, booking, records, refills, and home delivery, but most revenue still comes from exams, diagnostics, procedures, and pharmacy inside one care loop. Pharmacy works best as part of a full stack vet relationship.
  2 sacra
• This is also a brand problem. Chewy built loyalty through service and pricing, but younger pet owners increasingly want an app that feels like their actual vet, with messaging, care plans, reminders, and a clear path from virtual advice to physical treatment. That is a product and care design challenge, not a retail extension.
  1 sacra 2 sacra

The market is moving toward hybrid veterinary models where digital owns intake, triage, messaging, and follow up, and physical care handles diagnostics and treatment. Companies that combine both layers will capture pharmacy margin as part of ongoing care. Retail led entrants will keep moving prescriptions, but care led platforms will own the higher value relationship over time.